Instituto Nacional de ciberseguridad. Sección Incibe
Instituto Nacional de Ciberseguridad. Sección INCIBE-CERT

Go to Calendar     Go to Press Room     Go to Newsletters subscription

Search

CVE-2015-3965

Severity CVSS v4.0:
Pending analysis
Type:
CWE-264 Permissions, Privileges, and Access Control
Publication date:
23/03/2019
Last modified:
25/03/2019

Description

Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

Impact

Vector 3.x
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H CVSS v3.1 Severity and Metrics:

Base Score: 8.80 HIGH
Vector: CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector (AV): Network
Attack Complexity (AC): Low
Privileges Required (PR): Low
User Interaction (UI): None
Scope (S): Unchanged
Confidentiality (C): High
Integrity (I): High
Availability (A): High

Base Score 3.x
8.80
Severity 3.x
HIGH
Vector 2.0
AV:N/AC:L/Au:S/C:C/I:C/A:C CVSS v2.0 Severity and Metrics:

Base Score: 9.00 HIGH
Vector: AV:N/AC:L/Au:S/C:C/I:C/A:C

Attack Vector (AV): Network
Attack Complexity (AC): Low
Authentication (Au): Single
Confidentiality (C): Complete
Integrity (I): Complete
Availability (A): Complete

Base Score 2.0
9.00
Severity 2.0
HIGH

Vulnerable products and versions

CPE From Up to
cpe:2.3:o:pfizer:symbiq_infusion_system_firmware:*:*:*:*:*:*:*:* 3.13 (including)
cpe:2.3:h:pfizer:symbiq_infusion_system:-:*:*:*:*:*:*:*

To consult the complete list of CPE names with products and versions, see this page


References to Advisories, Solutions, and Tools